[250 Pages Report] The vertebroplasty and kyphoplasty devices market is expected to record a CAGR of 4.4% during the forecast period.
| Attributes | Details |
|---|---|
| Vertebroplasty and Kyphoplasty Devices Market CAGR | 4.4% |
| Vertebroplasty and Kyphoplasty Devices Market (2018) | US$ 1 Billion |
Sales of vertebroplasty and kyphoplasty devices are expected to rise as they are minimally invasive, image guided surgical procedures performed to treat the Vertebral Compression Fracture (VCF).
Back pain, depression, loss of independence, decreased lung capacity, and difficulty sleeping can all result from VCFs. Hence, treating the same carries importance which surges the demand for vertebroplasty and kyphoplasty devices.
In addition, the higher sales of vertebroplasty and kyphoplasty devices can be attributed to the help that it provides to the patient to regain functional abilities and avoid further vertebral collapse.
Demand for vertebroplasty and kyphoplasty devices spikes as kyphoplasty is an advanced version of vertebroplasty that can stabilize the fracture, restore heights and reduce deformities.
The syringe can be used to inject cement as well as inflate and deflate interventional devices. As a result, these factors are expected to increase the demand for vertebroplasty and kyphoplasty devices.
Due to people's changing lifestyles, the sales of vertebroplasty and kyphoplasty devices are expected to grow significantly.
Furthermore, an increase in demand for minimally invasive spine surgery procedures propels the demand for vertebroplasty and kyphoplasty devices and in turn, the sales of vertebroplasty and kyphoplasty devices.
The demand for vertebroplasty and kyphoplasty devices is being driven by an ageing population, which has resulted in an increase in the number of vertebral compression fractures and an increase in health-care expenditure.
Although specialty antibody applications are specifically used in research and diagnostic procedures, hospitals are a major end-user and the same facilitates the high demand for vertebroplasty and kyphoplasty devices.
The rising sales of vertebroplasty and kyphoplasty devices is also due to the improved hospital infrastructure in the United States, Europe, and other developed countries is strong.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Demand for vertebroplasty and kyphoplasty devices is growing due to limitations in the traditional techniques for the treatment of vertebral compression fractures.
Vertebroplasty and kyphoplasty are advanced procedure which result in pain relief, stabilization of the fracture and avoid “Downward spiral” of untreated osteoporosis thereby spikes the sales of vertebroplasty and kyphoplasty devices.
Due to increase in ageing population, patients suffering from osteoporosis are also increasing the sales of vertebroplasty and kyphoplasty devices.
The rising demand for vertebroplasty and kyphoplasty devices can be contributed to benefit of the surgery such as short surgical time where patient gets discharged in less than one day.
Sales of vertebroplasty and kyphoplasty devices grow as surgery involves requirement of general anaesthesia and non-requirement of bracing.
Complications like bleeding, infection post-surgery and chances of occurrence of another fracture are few restraints for the demand for vertebroplasty and kyphoplasty devices.
VCF is a major issue in the western countries driving the demand for vertebroplasty and kyphoplasty devices and in turn, sales of vertebroplasty and kyphoplasty devices.
Overall sales of vertebroplasty and kyphoplasty devices will grow globally, however the growth rate in Asia Pacific region will be more as compared to European and North American market.
Principal Consultant
Depending on geographic regions, the global vertebroplasty and kyphoplasty devices market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.
North America is the holding a major porting of the vertebroplasty and kyphoplasty devices market share due to the high volumes of surgical procedures being performed.
Also, the availability of established healthcare infrastructure, high contribution of healthcare to economy, patient compliance are the reasons for the high vertebroplasty and kyphoplasty devices market share of North America.
North America’s vertebroplasty and kyphoplasty devices market share can also be credited to the high prices of the kyphoplasty procedure in the United States, as well as the country's high incidence rate of vertebral compression fractures.
Europe has the second largest vertebroplasty and kyphoplasty devices market share due to vast technological advancement in terms of healthcare sector.
Asia Pacific market is expected to witness a good vertebroplasty and kyphoplasty devices market growth rate as compared to North America and Europe as there is ample market opportunity in countries like India and China.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Some of the key market players in global vertebroplasty and kyphoplasty devices market are Depuy Synthes, Stryker Corporation, CareFusion Corporation, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd.
In terms of vertebroplasty and kyphoplasty devices market share, a few major players currently dominate the market.
Companies have been launching strategic initiatives to expand their presence in the market under consideration.
| Report Attributes | Details |
|---|---|
| Growth rate | CAGR of 4.4% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 to 2020 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in US$ million, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Product, Region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | USA; Canada; Mexico; Germany; UK; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | Depuy Synthes, Stryker Corporation, CareFusion Corporation, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd., G-21 s.r.l., BMK Global Medical Company, Medtronic, Inc., Globus Medical, Inc. and SOMATEX. |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs.? |
The vertebroplasty and kyphoplasty devices market likely registers a CAGR of 4.4% during the forecast period.
Asia Pacific is expanding at the fastest rate owing to broad vertebroplasty and kyphoplasty devices market opportunities.
Depuy Synthes, Stryker Corporation, CareFusion Corporation, Osseon LLC., Alphatec Spine, Inc., TAEYEON MEDICAL Co., Ltd. are some of the key players in the vertebroplasty and kyphoplasty devices market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product, 2022-2032
5.3.1. Vertebroplasty Devices
5.3.2. Kyphoplasty Devices
5.4. Y-o-Y Growth Trend Analysis By Product, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Surgery
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Surgery, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Surgery, 2022-2032
6.3.1. Vertebroplasty
6.3.2. Kyphoplasty
6.4. Y-o-Y Growth Trend Analysis By Surgery, 2017-2021
6.5. Absolute $ Opportunity Analysis By Surgery, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Speciality Clinics
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
Deep-dive segmentation will be available in the sample on request
8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. East Asia
8.3.5. South Asia & Pacific
8.3.6. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Surgery
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Surgery
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Surgery
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Surgery
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Surgery
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Surgery
11.3.4. By End User
11.4. Key Takeaways
12. East Asia Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.2. By Product
12.2.3. By Surgery
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Surgery
12.3.4. By End User
12.4. Key Takeaways
13. South Asia & Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Thailand
13.2.1.3. Indonesia
13.2.1.4. Malaysia
13.2.1.5. Singapore
13.2.1.6. Australia
13.2.1.7. New Zealand
13.2.1.8. Rest of South Asia & Pacific
13.2.2. By Product
13.2.3. By Surgery
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Surgery
13.3.4. By End User
13.4. Key Takeaways
14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country
14.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
14.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
14.2.1. By Country
14.2.1.1. GCC Countries
14.2.1.2. South Africa
14.2.1.3. Israel
14.2.1.4. Rest of MEA
14.2.2. By Product
14.2.3. By Surgery
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Surgery
14.3.4. By End User
14.4. Key Takeaways
15. Key Countries Market Analysis
15.1. U.S.
15.1.1. Pricing Analysis
15.1.2. Market Share Analysis, 2021
15.1.2.1. By Product
15.1.2.2. By Surgery
15.1.2.3. By End User
15.2. Canada
15.2.1. Pricing Analysis
15.2.2. Market Share Analysis, 2021
15.2.2.1. By Product
15.2.2.2. By Surgery
15.2.2.3. By End User
15.3. Brazil
15.3.1. Pricing Analysis
15.3.2. Market Share Analysis, 2021
15.3.2.1. By Product
15.3.2.2. By Surgery
15.3.2.3. By End User
15.4. Mexico
15.4.1. Pricing Analysis
15.4.2. Market Share Analysis, 2021
15.4.2.1. By Product
15.4.2.2. By Surgery
15.4.2.3. By End User
15.5. Germany
15.5.1. Pricing Analysis
15.5.2. Market Share Analysis, 2021
15.5.2.1. By Product
15.5.2.2. By Surgery
15.5.2.3. By End User
15.6. U.K.
15.6.1. Pricing Analysis
15.6.2. Market Share Analysis, 2021
15.6.2.1. By Product
15.6.2.2. By Surgery
15.6.2.3. By End User
15.7. France
15.7.1. Pricing Analysis
15.7.2. Market Share Analysis, 2021
15.7.2.1. By Product
15.7.2.2. By Surgery
15.7.2.3. By End User
15.8. Spain
15.8.1. Pricing Analysis
15.8.2. Market Share Analysis, 2021
15.8.2.1. By Product
15.8.2.2. By Surgery
15.8.2.3. By End User
15.9. Italy
15.9.1. Pricing Analysis
15.9.2. Market Share Analysis, 2021
15.9.2.1. By Product
15.9.2.2. By Surgery
15.9.2.3. By End User
15.10. China
15.10.1. Pricing Analysis
15.10.2. Market Share Analysis, 2021
15.10.2.1. By Product
15.10.2.2. By Surgery
15.10.2.3. By End User
15.11. Japan
15.11.1. Pricing Analysis
15.11.2. Market Share Analysis, 2021
15.11.2.1. By Product
15.11.2.2. By Surgery
15.11.2.3. By End User
15.12. South Korea
15.12.1. Pricing Analysis
15.12.2. Market Share Analysis, 2021
15.12.2.1. By Product
15.12.2.2. By Surgery
15.12.2.3. By End User
15.13. India
15.13.1. Pricing Analysis
15.13.2. Market Share Analysis, 2021
15.13.2.1. By Product
15.13.2.2. By Surgery
15.13.2.3. By End User
15.14. Thailand
15.14.1. Pricing Analysis
15.14.2. Market Share Analysis, 2021
15.14.2.1. By Product
15.14.2.2. By Surgery
15.14.2.3. By End User
15.15. Indonesia
15.15.1. Pricing Analysis
15.15.2. Market Share Analysis, 2021
15.15.2.1. By Product
15.15.2.2. By Surgery
15.15.2.3. By End User
15.16. Malaysia
15.16.1. Pricing Analysis
15.16.2. Market Share Analysis, 2021
15.16.2.1. By Product
15.16.2.2. By Surgery
15.16.2.3. By End User
15.17. Singapore
15.17.1. Pricing Analysis
15.17.2. Market Share Analysis, 2021
15.17.2.1. By Product
15.17.2.2. By Surgery
15.17.2.3. By End User
15.18. Australia
15.18.1. Pricing Analysis
15.18.2. Market Share Analysis, 2021
15.18.2.1. By Product
15.18.2.2. By Surgery
15.18.2.3. By End User
15.19. New Zealand
15.19.1. Pricing Analysis
15.19.2. Market Share Analysis, 2021
15.19.2.1. By Product
15.19.2.2. By Surgery
15.19.2.3. By End User
15.20. GCC Countries
15.20.1. Pricing Analysis
15.20.2. Market Share Analysis, 2021
15.20.2.1. By Product
15.20.2.2. By Surgery
15.20.2.3. By End User
15.21. South Africa
15.21.1. Pricing Analysis
15.21.2. Market Share Analysis, 2021
15.21.2.1. By Product
15.21.2.2. By Surgery
15.21.2.3. By End User
15.22. Israel
15.22.1. Pricing Analysis
15.22.2. Market Share Analysis, 2021
15.22.2.1. By Product
15.22.2.2. By Surgery
15.22.2.3. By End User
16. Market Structure Analysis
16.1. Competition Dashboard
16.2. Competition Benchmarking
16.3. Market Share Analysis of Top Players
16.3.1. By Regional
16.3.2. By Product
16.3.3. By Surgery
16.3.4. By End User
17. Competition Analysis
17.1. Competition Deep Dive
17.1.1. Depuy Synthes
17.1.1.1. Overview
17.1.1.2. Product Portfolio
17.1.1.3. Profitability by Market Segments
17.1.1.4. Sales Footprint
17.1.1.5. Strategy Overview
17.1.1.5.1. Marketing Strategy
17.1.1.5.2. Product Strategy
17.1.1.5.3. Channel Strategy
17.1.2. Stryker Corporation
17.1.2.1. Overview
17.1.2.2. Product Portfolio
17.1.2.3. Profitability by Market Segments
17.1.2.4. Sales Footprint
17.1.2.5. Strategy Overview
17.1.2.5.1. Marketing Strategy
17.1.2.5.2. Product Strategy
17.1.2.5.3. Channel Strategy
17.1.3. Becton, Dickinson and Company
17.1.3.1. Overview
17.1.3.2. Product Portfolio
17.1.3.3. Profitability by Market Segments
17.1.3.4. Sales Footprint
17.1.3.5. Strategy Overview
17.1.3.5.1. Marketing Strategy
17.1.3.5.2. Product Strategy
17.1.3.5.3. Channel Strategy
17.1.4. Osteon Medical
17.1.4.1. Overview
17.1.4.2. Product Portfolio
17.1.4.3. Profitability by Market Segments
17.1.4.4. Sales Footprint
17.1.4.5. Strategy Overview
17.1.4.5.1. Marketing Strategy
17.1.4.5.2. Product Strategy
17.1.4.5.3. Channel Strategy
17.1.5. Alphatec Spine, Inc.
17.1.5.1. Overview
17.1.5.2. Product Portfolio
17.1.5.3. Profitability by Market Segments
17.1.5.4. Sales Footprint
17.1.5.5. Strategy Overview
17.1.5.5.1. Marketing Strategy
17.1.5.5.2. Product Strategy
17.1.5.5.3. Channel Strategy
17.1.6. G-21 s.r.l.
17.1.6.1. Overview
17.1.6.2. Product Portfolio
17.1.6.3. Profitability by Market Segments
17.1.6.4. Sales Footprint
17.1.6.5. Strategy Overview
17.1.6.5.1. Marketing Strategy
17.1.6.5.2. Product Strategy
17.1.6.5.3. Channel Strategy
17.1.7. BMK Global Medical Company
17.1.7.1. Overview
17.1.7.2. Product Portfolio
17.1.7.3. Profitability by Market Segments
17.1.7.4. Sales Footprint
17.1.7.5. Strategy Overview
17.1.7.5.1. Marketing Strategy
17.1.7.5.2. Product Strategy
17.1.7.5.3. Channel Strategy
17.1.8. Medtronic, Inc.
17.1.8.1. Overview
17.1.8.2. Product Portfolio
17.1.8.3. Profitability by Market Segments
17.1.8.4. Sales Footprint
17.1.8.5. Strategy Overview
17.1.8.5.1. Marketing Strategy
17.1.8.5.2. Product Strategy
17.1.8.5.3. Channel Strategy
17.1.9. Globus Medical, Inc.
17.1.9.1. Overview
17.1.9.2. Product Portfolio
17.1.9.3. Profitability by Market Segments
17.1.9.4. Sales Footprint
17.1.9.5. Strategy Overview
17.1.9.5.1. Marketing Strategy
17.1.9.5.2. Product Strategy
17.1.9.5.3. Channel Strategy
17.1.10. SOMATEX Medical Technologies GmbH
17.1.10.1. Overview
17.1.10.2. Product Portfolio
17.1.10.3. Profitability by Market Segments
17.1.10.4. Sales Footprint
17.1.10.5. Strategy Overview
17.1.10.5.1. Marketing Strategy
17.1.10.5.2. Product Strategy
17.1.10.5.3. Channel Strategy
17.1.11. TAEYEON MEDICAL Co. Ltd.
17.1.11.1. Overview
17.1.11.2. Product Portfolio
17.1.11.3. Profitability by Market Segments
17.1.11.4. Sales Footprint
17.1.11.5. Strategy Overview
17.1.11.5.1. Marketing Strategy
17.1.11.5.2. Product Strategy
17.1.11.5.3. Channel Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Explore Healthcare Insights
View Reports
Vertebroplasty And Kyphoplasty Devices Market
